Medical R&D news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
California Hep A outbreak could prove costly to local healthcare providers Health officials in Los Angeles County on Tuesday declared an outbreak of Hepatitis A infection after two local cases were identified. Since November, the virus has killed 16 people in San Diego. A total of 10 cases have been reported in Los Angeles County as of Tuesday, according to public health officials. Four of those people ... Read More
Hospital stocks advance even as ACA repeal vote looms Investor jitters over a looming vote on the latest Obamacare repeal-and-replace bill eased Wednesday and healthcare stocks regained some of ground they lost during a sell-off Tuesday. Three of the nation’s largest hospital chains—HCA, LifePoint Health and Universal Health Services—had each posted 1% gains in share prices Wednesday as of 2:00 p.m. ET. Tenet Healthcare and Community ... Read More
McConnell plans floor vote on Graham-Cassidy bill Developing storyWhat seemed like a long shot just last week is suddenly inching closer to reality. Legislation crafted by Sens. Lindsey Graham (R-S.C.), and Bill Cassidy (R-La.) is expected to get a floor vote next week. “It is the leader’s intention to consider Graham-Cassidy on the floor next week,” said David Popp, spokesman for Senate Majority ... Read More
Anthem set to acquire Florida Medicare Advantage plan Anthem agreed Wednesday to buy HealthSun, a growing Medicare Advantage plan with 40,000 members and a network of clinics in south Florida. Terms were not disclosed. The HealthSun addition will give Anthem 650,000 Medicare and Medicaid members across Florida, Anthem said in a release Wednesday. The insurance giant in 2015 began expanding its Medicare Advantage market ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
Can Better Relationships Improve Clinical Trials? A classic problem in clinical research has been patient awareness. That is one reason why the industry has turned to advertising to get the message about trials out to the patients. But that does not mean we are doing a better job of increasing awareness. Read More